Nkarta Therapeutics
South San Francisco, CA
Nkarta, Inc. operates as a biotech company. The Company develops and discovers therapies for immune systems and cancer indications. Nkarta serves patients in the State of California.
nkartatx.comCompany Details
Founded
- 2015
Employees
- 109 employees
Raised
- $595,000,000
Headquarters Location
- South San Francisco, CA
Public
- Yes
Acquired
- No
CEO
Paul Hastings
Founders
- Alena NoskovaDario Campana
Company Collections
These are collections Nkarta Therapeutics is a part of. Click on the collection name to view similar companies.
Nkarta Therapeutics' Industries
Company Collections For Nkarta Therapeutics
Current Job Listings
Listing 0 of 2 job openings
Nkarta Therapeutics Headquarters Location
6000 Shoreline Ct suite 102, South San Francisco, CA 94080
Total Amount Raised: $595,000,000
Nkarta Therapeutics Funding Rounds
Post Ipo Equity
$240,000,000
Post Ipo Equity Investors
Boxer CapitalSamsara BioCapitalCormorant Asset ManagementRidgeback Capital ManagementJanus Henderson GroupCommodore CapitalAdage Capital ManagementOrbiMed AdvisorsSr OneRA Capital ManagementEcoR1 CapitalPost Ipo Equity
$230,000,000
IPO
Unknown
Series B
$114,000,000
Series B Investors
Samsara BioCapitalRA Capital ManagementLogos CapitalLife Sciences PartnersDeerfield ManagementAmgenNovo HoldingsNEA - New Enterprise AssociatesSr OneSeries A
$11,000,000
Series A Investors
NEA - New Enterprise AssociatesNovo HoldingsSr One
Funding info provided by Diffbot.
Nkarta Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Nkarta Therapeutics.